Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sharon Richards"'
Autor:
Alexander Zarbock, Pierre-François Laterre, Peter Pickkers, Rinaldo Bellomo, Paul Young, Derek C Angus, Kent Doi, Michael Joannidis, Marlies Ostermann, Morten Bestle, Ravindra L Mehta, Patrick T Murray, John A Kellum, Jacques Arend, Christopher J Doig, Ville Pettilä, Bruno Francois, Erik van den Berg, Juliane Bernholz, Kristine Broglio, Jan Carlsen, Ricard Ferrer, Kathleen Liu, Sharon Richards, Anne Louise Kjølbye
Publikováno v:
BMJ Open, Vol 13, Iss 4 (2023)
Introduction Sepsis, the leading cause of acute kidney injury (AKI), is associated with a high morbidity and mortality. Alkaline phosphatase (ALP) is an endogenous detoxifying enzyme. A recombinant human ALP compound, ilofotase alfa, showed no safety
Externí odkaz:
https://doaj.org/article/409c425fa54047969891edcb40c58ebb
Autor:
Peter Pickkers, Derek C Angus, Jacques Arend, Rinaldo Bellomo, Erik van den Berg, Juliane Bernholz, Morten Bestle, Kristine Broglio, Jan Carlsen, Christopher J Doig, Ricard Ferrer, Michael Joannidis, Bruno Francois, Kent Doi, John A Kellum, Pierre-François Laterre, Kathleen Liu, Ravindra L Mehta, Patrick T Murray, Marlies Ostermann, Ville Pettilä, Sharon Richards, Paul Young, Alexander Zarbock, Anne Louise Kjølbye
Publikováno v:
Pickkers, P, Angus, D C, Arend, J, Bellomo, R, Van Den Berg, E, Bernholz, J, Bestle, M, Broglio, K, Carlsen, J, Doig, C J, Ferrer, R, Joannidis, M, Francois, B, Doi, K, Kellum, J A, Laterre, P F, Liu, K, Mehta, R L, Murray, P T, Ostermann, M, Pettilä, V, Richards, S, Young, P, Zarbock, A & Kjølbye, A L 2023, ' Study protocol of a randomised, double-blind, placebo-controlled, two-arm parallel-group, multi-centre phase 3 pivotal trial to investigate the efficacy and safety of recombinant human alkaline phosphatase for treatment of patients with sepsis-associated acute kidney injury ', BMJ Open, vol. 13, no. 4, e065613 . https://doi.org/10.1136/bmjopen-2022-065613
BMJ Open, 13
BMJ Open, 13, 4
BMJ Open, 13
BMJ Open, 13, 4
IntroductionSepsis, the leading cause of acute kidney injury (AKI), is associated with a high morbidity and mortality. Alkaline phosphatase (ALP) is an endogenous detoxifying enzyme. A recombinant human ALP compound, ilofotase alfa, showed no safety
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdcc74f438a98953a27b573f59256a08
https://curis.ku.dk/ws/files/344643363/e065613.full.pdf
https://curis.ku.dk/ws/files/344643363/e065613.full.pdf
Publikováno v:
Journal of Integrated Care, 2015, Vol. 23, Issue 4, pp. 219-231.
Externí odkaz:
http://www.emeraldinsight.com/doi/10.1108/JICA-06-2015-0021
Autor:
Stefan D. Anker, Kai-Uwe Eckardt, Florian Kronenberg, Daniele Marcelli, Peter Stenvinkel, Sharon Richards, Tilman B. Drüeke, Marc Froissart, Ronald L. Pisoni, Iain A. Gillespie, Bruce M. Robinson, Jürgen Floege
Publikováno v:
International Journal of Cardiology. 216:68-77
Background A simple clinical tool to predict cardiovascular disease risk does not exist for haemodialysis patients. The long-term coronary risk Framingham Heart Study Risk score (FRS), although used in this population, may be inadequate. Therefore, w
Publikováno v:
Journal of Integrated Care. 23:219-231
Purpose The purpose of this paper is to understand the strategic role of third-sector agencies, with a history that often left them “sidelined” by the public sector, showing how all agencies involved can be respected and trusted, with conflicts o
Autor:
Iain A. Gillespie, Marc Froissart, Kai-Uwe Eckardt, Vincent Jones, Iain C. Macdougall, Daniele Marcelli, Sharon Richards
Publikováno v:
Pharmacoepidemiology and Drug Safety
Purpose Hyporesponsiveness to erythropoiesis-stimulating agents (ESAs) is clinically and economically important in the treatment of anaemia in chronic kidney disease (CKD) patients. Previous studies focused on baseline predictors of ESA hyporesponsiv
Autor:
Stefan D. Anker, Marc Froissart, Ioanna Gioni, Bruce M. Robinson, Kai-Uwe Eckardt, Iain A. Gillespie, Daniele Marcelli, Florian Kronenberg, Sharon Richards, Jürgen Floege, Ronald L. Pisoni
Publikováno v:
Kidney international 87(5), 996-1008 (2015). doi:10.1038/ki.2014.419
Kidney International
Kidney International
Although mortality risk scores for chronic hemodialysis (HD) patients should have an important role in clinical decision-making, those currently available have limited applicability, robustness, and generalizability. Here we applied a modified Framin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd3613ffacecca57a6960e8d78aa721e
Autor:
Kai-Uwe, Eckardt, Iain A, Gillespie, Florian, Kronenberg, Sharon, Richards, Peter, Stenvinkel, Stefan D, Anker, David C, Wheeler, Angel L, de Francisco, Daniele, Marcelli, Marc, Froissart, Jürgen, Floege, B, Canaud
Publikováno v:
Kidney International, 2015, 88(5), 1117-25
Early mortality is high in hemodialysis (HD) patients, but little is known about early cardiovascular event (CVE) rates after HD initiation. To study this we analyzed data in the AROii cohort of incident HD patients from over 300 European Fresenius M